Skip to main content
HISAMITSU PHARMACEUTICAL CO.,INC. logo

HISAMITSU PHARMACEUTICAL CO.,INC. — Investor Relations & Filings

Ticker · 4530 ISIN · JP3784600003 LEI · 5299006QL3IBQ4CN7E12 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-04-28 Major Shareholding Noti…
Country JP Japan
Listing T 4530

About HISAMITSU PHARMACEUTICAL CO.,INC.

https://global.hisamitsu/

Hisamitsu Pharmaceutical Co., Inc. is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter (OTC) products. The company specializes in external pain relief medications, utilizing advanced transdermal drug delivery system (TDDS) technology. Its core product portfolio includes topical analgesics and anti-inflammatory formulations, such as plasters, patches, and poultices. A key brand in its OTC segment is Salonpas, a globally recognized line of pain-relieving patches. The company serves both consumer healthcare and prescription markets worldwide, focusing on providing solutions for musculoskeletal pain and inflammation.

Recent filings

Filing Released Lang Actions
臨時報告書
Major Shareholding Notification Classification · 88% confidence The document is a 臨時報告書 (extraordinary report) under Japan's Financial Instruments and Exchange Act, disclosing a change in major shareholdings resulting in a shareholder crossing voting‐right thresholds (from 0.36% to 33.33%). This corresponds exactly to a Major Shareholding Notification (MRQ).
2026-04-28 Japanese
臨時報告書
Declaration of Voting Results & Voting Rights Announcements Classification · 88% confidence The document is a Japanese "臨時報告書" filed under the Financial Instruments and Exchange Law, detailing the resolutions passed at an Extraordinary General Meeting held on April 17, 2026. It provides the items voted on (share consolidation and articles amendment), the meeting date, the vote counts for each proposal, and the results. This matches the “Declaration of Voting Results & Voting Rights Announcements” category, which covers official results from shareholder votes at any general meeting (AGM or EGM).
2026-04-20 Japanese
株式併合並びに単元株式数の定めの廃止及び定款の一部変更の承認決議に関するお知らせ
Regulatory Filings
2026-04-17 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Status of Purchase of Own Shares' (自己株券買付状況報告書) filed under the Financial Instruments and Exchange Act. It details the company's share repurchase activity for the period of December 2025, including the number of shares acquired and the total cost. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-01-07 Japanese
意見表明報告書
M&A Activity Classification · 98% confidence The document is a 'Statement of Opinion Regarding Tender Offer' (意見表明報告書) filed by Hisamitsu Pharmaceutical Co., Inc. in response to a tender offer (MBO) initiated by Taiyo Kosan Co., Ltd. This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan when a company expresses its position on a takeover bid. It details the tender offer terms, the board's recommendation, and the fairness measures taken. This fits the 'Regulatory Filings' category as it is a specific legal disclosure document regarding M&A activity that does not fall under standard earnings releases or annual reports.
2026-01-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Purchase of Own Shares' (自己株券買付状況報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the specific dates, number of shares purchased, and total cost of share buybacks conducted by Hisamitsu Pharmaceutical Co., Inc. during the month of November 2025. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-12-03 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.